ESOMAR certified consulting firm Future Market Insights (FMI) has recently published an exhaustive yet unbiased report on the global oxytocin market, highlighting the prominent parameters responsible for steering growth in the long-run. The study opines global oxytocin sales to grow at over 8% through 2030, with a growing focus on preventing PPH incidences expected to drive demand.
From 2022 to 2030, the global oxytocin market is projected to increase significantly at a 9.0% CAGR, with a market value of about US$ 83.0 Million in 2022. According to Future Market Insights’ predictions, Postpartum type will command a sizeable proportion of the global market in 2021, amounting to about 88.8%.
While the frequency of childbirths is increasing, the number of complications faced by women are also compounding. The Center for Disease Control and Prevention estimates that over 50,000 women across the U.S. endure life-threatening complications.
Request a sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-11218
Consequently, healthcare providers are incorporating solutions aimed at reducing trauma faced by patients which include numerous approaches. A common complication faced by women is postpartum hemorrhage, for which oxytocin treatment is a highly preferred option. A value CAGR exceeding 8% is projected for the market through 2030.
The Oxytocin market holds nearly 6.3% of the overall US$ 1.2 Bn Growth Hormones market in 2021.
The market of oxytocin on a global scale is considered extremely fragmented, with numerous local and multinational players active. Most products purchased from local players are provided by the National Government Procurement Agencies to the local governments. Thus, several developing countries are dependent upon local players, leading to an increase in focus on procurement of high volumes for lower costs.
The global oxytocin market includes an increase in the licensing activities of companies to develop new therapeutics for a range of indications.
Key Takeaways
Postpartum hemorrhage (PPH) solutions to comprise nearly 90% of the revenue share in 2020 by product type
Hospital pharmacies remain key distribution channels, online pharmacies’ popularity to widen
Opportunities abound across the Middle East & Africa (MEA) owing to rising PPH incidence in Africa
Global oxytocin market is projected to reach US$ nearly US$ 165 Mn by 2030
“Government initiatives to promote women and children’s health are bolstering global efforts to improve maternity care across healthcare settings, thereby opening significant growth avenues for the global oxytocin market,” comments the FMI analyst.
Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-11218
Therefore, efforts are being made towards ensuring adequate and proper treatment to pregnant women across all regions. Furthermore, oxytocin has also been touted as an effective anti-viral agent, thus raising optimism that it could be effectively leveraged to promote drug or vaccine development.
The National Center for Biotechnology Information hypothesizes that oxytocin contains dipeptidyl peptidase-4 (DPP4) protease inhibitors could be effective against the existing novel coronavirus strain. It further propagates that enhancing endogenous oxytocin levels could increase viral resistance and improve health of vulnerable groups.
Key Market Segments Covered in Oxytocin Industry Research
By Product:
Antepartum
Postpartum
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Contact Sales for Further Assistance in Purchasing this Report @
https://www.futuremarketinsights.com/checkout/11218
Competitive Landscape
Prominent players in the global oxytocin market include Pfizer Inc., Novartis AG, Ferring B.V., Fresenius Kabi LLC, Hikma Pharmaceuticals PLC, Endo International Plc. (Par Sterile Products, LLC), Teva Pharmaceuticals Ltd., Mylan N.V., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd. and Yuhan Corporation.
The market is highly fragmented, peppered with numerous regional and global level market players. These players largely concentrate on forging strategic collaborations with existing players, regional distributors, product launches and acquisitions. Most players are concentrating on offering anesthetic oxytocin solutions to reduce labor induced complications for C-section operations.
About Us
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs
